Q4 2021 Gossamer Bio Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Gossamer Bio Q4 Earnings Call. (Operator Instructions) Without further ado, I would like to welcome your speaker for today, Mr. Bryan Giraudo. Sir, the floor is yours.
Thank you, operator, and thank you all for joining us this afternoon. I am joined on today's call by Gossamer's Co-Founder, Chairman and Chief Executive Officer, Faheem Hasnain; Gossamer's Chief Medical Officer, Dr. Richard Aranda; and Gossamer's Chief Scientific Officer, Dr. Laura Carter.
Earlier today, Gossamer issued a press release announcing its year-end 2021 financial results and provide a corporate update. Please note that certain information discussed on the call is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during this call, Gossamer management will be making forward-looking statements. Actual results may differ materially from those stated or implied by these forward-looking statements due to risks and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |